Clinical evaluation of medical devices and in vitro diagnostics (IVDs) is a critical area for M.Pharm students involved in clinical research and regulatory affairs. This blog provides focused multiple-choice questions to deepen understanding of regulatory frameworks (MDR/IVDR), clinical investigation requirements, performance evaluation, post-market clinical follow-up (PMCF), and evidence generation strategies. Each question highlights practical concepts such as study design, equivalence, analytical vs clinical performance, risk–benefit assessment, vigilance, and the role of Notified Bodies. These MCQs are designed to reinforce theory and prepare students for real-world regulatory submissions and clinical assessments of devices and diagnostics.
Q1. Which document summarizes all clinical data and justifies the clinical safety and performance of a medical device under the EU MDR?
- Technical File
- Clinical Evaluation Report (CER)
- Investigator Brochure
- Risk Management Plan
Correct Answer: Clinical Evaluation Report (CER)
Q2. Under EU IVDR, which study type is primarily used to demonstrate the diagnostic accuracy (sensitivity and specificity) of an IVD in its intended use population?
- Analytical performance study
- Clinical performance study
- Usability (human factors) study
- Biocompatibility study
Correct Answer: Clinical performance study
Q3. Which regulatory requirement ensures continued collection of clinical data for a device already on the market to confirm its long-term safety and performance?
- Pre-market clinical investigation
- Post-Market Clinical Follow-up (PMCF)
- Investigational Device Exemption (IDE)
- Technical Documentation Update
Correct Answer: Post-Market Clinical Follow-up (PMCF)
Q4. For an IVD, which parameter is primarily assessed in an analytical performance study rather than a clinical performance study?
- Sensitivity
- Specificity
- Limit of detection (LoD)
- Positive predictive value
Correct Answer: Limit of detection (LoD)
Q5. When claiming equivalence to a predicate device for clinical evaluation, which aspect must be demonstrated?
- Same price and manufacturer
- Similarity in intended use, design, and clinical safety/performance
- Identical packaging and labeling
- Same number of clinical studies
Correct Answer: Similarity in intended use, design, and clinical safety/performance
Q6. Which body is responsible for conformity assessment and issuing CE certificates for higher‑risk medical devices in the EU?
- European Medicines Agency (EMA)
- Notified Body
- National Competent Authority of the manufacturer’s country only
- World Health Organization (WHO)
Correct Answer: Notified Body
Q7. What is the primary purpose of a Clinical Evaluation Plan (CEP) in the clinical evaluation process?
- To replace the technical documentation
- To define objectives, methods, and criteria for gathering clinical evidence
- To list investigators for post‑market studies
- To summarize the marketing strategy
Correct Answer: To define objectives, methods, and criteria for gathering clinical evidence
Q8. Which term best describes the benefit-risk conclusion required by regulators for device approval?
- Commercial viability
- Acceptable benefit-risk ratio
- Maximal sensitivity irrespective of harms
- Zero risk standard
Correct Answer: Acceptable benefit-risk ratio
Q9. In an IVD clinical performance study, why is the choice of the reference standard critical?
- Reference standard is optional and has no impact
- It determines the validity of sensitivity/specificity estimates
- It sets the device’s shelf life
- It defines the user training requirements
Correct Answer: It determines the validity of sensitivity/specificity estimates
Q10. Which of the following is a key difference between analytical and clinical performance evaluations of IVDs?
- Analytical evaluates clinical outcomes; clinical evaluates laboratory precision
- Analytical assesses characteristics like LoD and precision; clinical assesses diagnostic accuracy in patients
- Analytical is performed only after market approval; clinical only before
- There is no difference; the terms are interchangeable
Correct Answer: Analytical assesses characteristics like LoD and precision; clinical assesses diagnostic accuracy in patients
Q11. Which regulatory document under MDR defines classes of medical devices (I, IIa, IIb, III)?
- ISO 13485
- EU MDR 2017/745
- IVDR 2017/746
- ICH E6 (R2)
Correct Answer: EU MDR 2017/745
Q12. Which study design reduces selection bias by assigning subjects to device or comparator groups using a random process?
- Case series
- Randomized controlled trial (RCT)
- Cross-sectional survey
- Historical control study
Correct Answer: Randomized controlled trial (RCT)
Q13. What is the primary objective of usability (human factors) testing for medical devices?
- To establish manufacturing tolerances
- To identify use-related hazards and reduce user errors
- To evaluate analytical sensitivity
- To determine post-market pricing
Correct Answer: To identify use-related hazards and reduce user errors
Q14. Which vigilance term refers to an action taken to reduce a risk of a serious incident associated with a device already placed on the market?
- Market surveillance audit
- Field Safety Corrective Action (FSCA)
- Pre-market approval
- Clinical evaluation report
Correct Answer: Field Safety Corrective Action (FSCA)
Q15. For diagnostic tests, how does disease prevalence in the tested population affect positive predictive value (PPV)?
- Higher prevalence decreases PPV
- Prevalence has no effect on PPV
- Higher prevalence increases PPV
- PPV depends only on specificity
Correct Answer: Higher prevalence increases PPV
Q16. Which element is essential in a Clinical Investigation Plan (CIP) for a device study?
- Marketing budget details
- Study objectives, endpoints, and statistical analysis plan
- List of competitor products only
- Manufacturer’s internal audit schedule
Correct Answer: Study objectives, endpoints, and statistical analysis plan
Q17. Under IVDR, which classification rule generally covers high-risk companion diagnostics?
- Rule A: Class A
- Class D high-risk
- Class B moderate risk
- All IVDs are Class A by default
Correct Answer: Class D high-risk
Q18. Which statistical measure is most appropriate to describe the agreement between a new diagnostic test and a reference method for categorical outcomes?
- Mean difference
- Cohen’s kappa
- Pearson correlation coefficient
- Standard deviation
Correct Answer: Cohen’s kappa
Q19. What is a key consideration when using retrospective data sources for clinical evidence generation?
- Retrospective data always eliminates confounding
- Potential biases and missing data that may affect validity
- They automatically satisfy PMCF requirements
- They are preferred when randomized trials are inexpensive
Correct Answer: Potential biases and missing data that may affect validity
Q20. Which document should demonstrate how residual risks are acceptable in light of the clinical benefits of a device?
- Clinical Evaluation Report (CER)
- Device label only
- Manufacturer’s sales brochure
- Packaging insert graphics
Correct Answer: Clinical Evaluation Report (CER)
